
|Articles|February 1, 2005
DC-based vaccines gaining ground
Tampa, Fla. — Although development of melanoma vaccines based on dendritic cells (DCs) lags behind that of more established approaches, it's rapidly moving from the lab bench into clinical trials.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
2
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
3
When Hives Do Not Quit: A Practical Update on Chronic Spontaneous Urticaria
4
The Weekly Roundup: December 8-12
5


















